Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 916542 Boston, MA
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,186,609
+$4,249,418 QoQ
Shares Held
111,516
+515.1% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#60
of 335 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $533,943,071 across 32 Drug Manufacturers - Specialty & Generic names. SUPN ranks #15 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 318,320 $172,475,325
2 NBIX
Neurocrine Biosciences Inc
 441,371 $74,388,668
3 KNSA
Kiniksa Pharmaceuticals International, plc
 679,083 $43,427,357
4 RDY
Dr Reddys Laboratories Ltd
 2,260,243 $32,750,921
5 INDV
Indivior Pharmaceuticals, Inc.
 733,974 $30,114,953
6 AMRX
Amneal Pharmaceuticals, Inc.
 1,650,255 $28,565,914
7 BHC
Bausch Health Companies Inc.
 5,482,986 $27,031,120
8 ZTS
Zoetis Inc.
 364,442 $26,188,802

All Filings in SUPN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,186,609 111,516
2026-03-31 $937,191 18,131
2025-12-31 $15,241,250 306,665
2025-09-30 $10,711,793 224,143
2025-06-30 $289,164 9,174
2025-03-31 $300,448 9,174
2024-12-31 $80,998 2,240
2024-09-30 $42,498 1,363
2021-03-31 $347,094 13,258
2020-12-31 $4,493,299 178,589
2020-09-30 $8,699,887 417,461
2020-06-30 $15,934,231 670,915
2020-03-31 $7,563,859 420,448